Literature DB >> 30702894

Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults.

Loïc Dayon1, Ornella Cominetti1, Jérôme Wojcik2, Antonio Núñez Galindo1, Aikaterini Oikonomidi3, Hugues Henry4, Eugenia Migliavacca1, Martin Kussmann1, Gene L Bowman1, Julius Popp3,5.   

Abstract

The systems-level relationship between the proteomes of cerebrospinal fluid (CSF) and plasma has not been comprehensively described so far. Recently developed shotgun proteomic workflows allow for deeper characterization of the proteomes from body fluids in much larger sample size. We deployed state-of-the-art mass spectrometry-based proteomics in paired CSF and plasma samples volunteered by 120 elders with and without cognitive impairment to comprehensively characterize and examine compartmental proteome differences and relationships between both body fluids. We further assessed the influence of blood-brain barrier (BBB) integrity and tested the hypothesis that BBB breakdown can be identified from CSF and plasma proteome alterations in nondemented elders. We quantified 790 proteins in CSF and 422 proteins in plasma, and 255 of the proteins were identified in both compartments. Pearson's statistics determined 28 proteins with associated levels between CSF and plasma. BBB integrity as defined with the CSF/serum albumin index influenced 76 CSF/plasma protein ratios. In least absolute shrinkage and selection operator models, CSF and plasma proteins improved identification of BBB impairment. In conclusion, we provide here a first comprehensive draft map of interacting human CSF and plasma proteomes, in view of their complex and dynamic compositions, and influence of the BBB.

Entities:  

Keywords:  BBB; CSF; blood; brain; cerebrospinal fluid; circulation; clinical proteomics; mass spectrometry; nervous system; serum/plasma

Mesh:

Substances:

Year:  2019        PMID: 30702894     DOI: 10.1021/acs.jproteome.8b00809

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  11 in total

1.  Plasma proteome profiling identifies changes associated to AD but not to FTD.

Authors:  R Babapour Mofrad; M Del Campo; C F W Peeters; L H H Meeter; H Seelaar; M Koel-Simmelink; I H G B Ramakers; H A M Middelkoop; P P De Deyn; J A H R Claassen; J C van Swieten; C Bridel; J J M Hoozemans; P Scheltens; W M van der Flier; Y A L Pijnenburg; Charlotte E Teunissen
Journal:  Acta Neuropathol Commun       Date:  2022-10-22       Impact factor: 7.578

2.  Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people.

Authors:  Christopher Clark; Jonas Richiardi; Bénédicte Maréchal; Gene L Bowman; Loïc Dayon; Julius Popp
Journal:  J Neuroinflammation       Date:  2022-05-28       Impact factor: 9.587

Review 3.  Proteomic-based evidence for adult neurogenesis in birds and mammals as indicated from cerebrospinal fluid.

Authors:  Eleni Voukali; Michal Vinkler
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

4.  Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.

Authors:  Erik C B Johnson; Eric B Dammer; Duc M Duong; Lingyan Ping; Maotian Zhou; Luming Yin; Lenora A Higginbotham; Andrew Guajardo; Bartholomew White; Juan C Troncoso; Madhav Thambisetty; Thomas J Montine; Edward B Lee; John Q Trojanowski; Thomas G Beach; Eric M Reiman; Vahram Haroutunian; Minghui Wang; Eric Schadt; Bin Zhang; Dennis W Dickson; Nilüfer Ertekin-Taner; Todd E Golde; Vladislav A Petyuk; Philip L De Jager; David A Bennett; Thomas S Wingo; Srikant Rangaraju; Ihab Hajjar; Joshua M Shulman; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Nat Med       Date:  2020-04-13       Impact factor: 53.440

5.  Proteomic Profiling of Extracellular Vesicles Isolated From Cerebrospinal Fluid of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy.

Authors:  Satoshi Muraoka; Mark P Jedrychowski; Harutsugu Tatebe; Annina M DeLeo; Seiko Ikezu; Takahiko Tokuda; Steven P Gygi; Robert A Stern; Tsuneya Ikezu
Journal:  Front Neurosci       Date:  2019-10-09       Impact factor: 4.677

6.  An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.

Authors:  Christopher Clark; Loïc Dayon; Mojgan Masoodi; Gene L Bowman; Julius Popp
Journal:  Alzheimers Res Ther       Date:  2021-04-01       Impact factor: 6.982

7.  Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.

Authors:  Pieter Jelle Visser; Lianne M Reus; Johan Gobom; Iris Jansen; Ellen Dicks; Sven J van der Lee; Magda Tsolaki; Frans R J Verhey; Julius Popp; Pablo Martinez-Lage; Rik Vandenberghe; Alberto Lleó; José Luís Molinuevo; Sebastiaan Engelborghs; Yvonne Freund-Levi; Lutz Froelich; Kristel Sleegers; Valerija Dobricic; Simon Lovestone; Johannes Streffer; Stephanie J B Vos; Isabelle Bos; August B Smit; Kaj Blennow; Philip Scheltens; Charlotte E Teunissen; Lars Bertram; Henrik Zetterberg; Betty M Tijms
Journal:  Mol Neurodegener       Date:  2022-03-28       Impact factor: 14.195

8.  Methods to capture proteomic and metabolomic signatures from cerebrospinal fluid and serum of healthy individuals.

Authors:  Laura M Lilley; Steven Sanche; Shepard C Moore; Michelle R Salemi; Dung Vu; Srinivas Iyer; Nicolas W Hengartner; Harshini Mukundan
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

9.  Raphe and ventrolateral medulla proteomics in epilepsy and sudden unexpected death in epilepsy.

Authors:  Dominique F Leitner; Evgeny Kanshin; Manor Askenazi; Arline Faustin; Daniel Friedman; Sasha Devore; Beatrix Ueberheide; Thomas Wisniewski; Orrin Devinsky
Journal:  Brain Commun       Date:  2022-07-12

10.  Comparison of plasma and cerebrospinal fluid proteomes identifies gene products guiding adult neurogenesis and neural differentiation in birds.

Authors:  Eleni Voukali; Nithya Kuttiyarthu Veetil; Pavel Němec; Pavel Stopka; Michal Vinkler
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.